This rat monoclonal antibody was generated against a full-length BH3-interacting domain death agonist (BID) bacterial fusion protein and is specific to human BID.
BID is a pro-apoptotic member of the Bcl-2 protein family that acts as a direct activator of Bax and the caspase cascade. BID has also been demonstrated to have a role in p53-mediated apoptosis.
From a laboratory at Harvard University.
Part of The Investigator's Annexe program.
|Name:||Anti-human Bid (1H11)|
|Immunogen:||Bacterial fusion protein(full length).|
|Purity:||Protein G affinity purified|
|Tested Applications:||WB (1-5 ug/mL), ELISA, IHC-P (20 ug/mL)|
|Storage:||Store at 4C|
If you publish research with this product, please let us know so we can cite your paper.